Developing a New Tool to Study Viral Infections and Cancer in Dogs
Researchers will develop a state-of-the-art molecular tool to track and study killer T-cell populations that are responsible for fighting viral infections and cancer in dogs.
Researchers will develop a state-of-the-art molecular tool to track and study killer T-cell populations that are responsible for fighting viral infections and cancer in dogs.
Researchers will investigate targeted therapies for the treatment of B-cell lymphoma in dogs.
Researchers will investigate the efficacy of the drug tramadol in relieving pain in dogs with osteoarthritic joints.
Researchers will investigate how osteosarcoma spreads, in the hopes of finding new treatment targets.
Researchers will investigate potential new medical treatments for canine Cushing's syndrome.
Researchers will improve techniques for monitoring anticoagulant therapy and preventing blood clot complications in dogs with immune-mediated hemolytic anemia.
Researchers will investigate the prevalence of, and factors contributing to, parvovirus (a highly contagious viral disease) in African carnivores.
Researchers will investigate the potential impact and transmission of a blood bacteria in the critically endangered Darwin's fox.
Researchers will validate a diagnostic tool to measure coagulation and establish normal clotting ranges in great horned owls and red-tailed hawks to improve diagnostics for raptors exposed to deadly, anticoagulant rodent poisons.
Researchers will investigate the prevalence and geographical distribution of koala retrovirus and chlamydia infections in koalas to identify populations with disease-free animals to assist conservation efforts.